Literature DB >> 35849400

Analysis of Hospitalization and Mortality by Race and Ethnicity Among Adults With Variceal Upper Gastrointestinal Hemorrhage, 2008-2018.

Umer Farooq1, Zahid Ijaz Tarar2, Harleen Kaur Chela3, Veysel Tahan3, Ebubekir Daglilar3.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35849400      PMCID: PMC9294996          DOI: 10.1001/jamanetworkopen.2022.22419

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


× No keyword cloud information.

Introduction

The overall mortality trends from variceal upper gastrointestinal hemorrhage (VUGIH) have been reported as decreasing (1989-1999) with an undulating incidence trend.[1] There is limited literature addressing racial and ethnic differences in longitudinal incidence and related mortality trends of VUGIH.[2] We conducted a longitudinal assessment of the racial and ethnic breakdown of incidence and mortality from VUGIH in the US during 11 years (2008-2018).

Methods

This cohort study was a retrospective longitudinal trend analysis using National Inpatient Sample following the STROBE reporting guideline.[3] All adults (age ≥18 years) with VUGIH were identified using the International Classification of Diseases, Ninth Revision (ICD-9) and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) codes for the corresponding years. Multilevel logistic mixed-effects regression models were used to address sample clustering (eMethods in the Supplement). The yearly incidence rate per 100 000 was calculated based on the US population estimate on July 1 of the corresponding year obtained from the US Census Bureau. Stata, version 14.2 (StataCorp LLC) was used to perform analyses, with 2-sided P < .05 considered statistically significant. The institutional review board of Loyola University Medical Center deemed the study exempt from review and the requirement for informed consent owing to the use of deidentified publicly available data.

Results

A total of 234 982 patients with VUGIH were included. Mean age at presentation increased longitudinally, and hospital length of stay decreased from 6.45 days in 2008 to 6.17 days in 2018 (P = .01) (Table). Men had more hospitalizations than women during the entirety study (men, 26 615 [67.6%] to 26 223 [70.1%] vs women, 11 169 [29.9%] to 12 780 [32.4%]). The overall incidence of VUGIH increased from 11.82 per 100 000 persons in 2008 to 13.67 per 100 000 persons in 2018 (P < .001). Incidence trends increased from 2008 to 2018 in Hispanic and White individuals, whereas stable trends were noticed in Asian and Black individuals (Figure). The overall adjusted mortality from VUGIH decreased from 10.9% in 2008 to 9.6% in 2018 (P = .003). Mortality rates decreased in Black (P = .03 for trend) and Hispanic (P = .004 for trend) individuals only on longitudinal analysis. Racial and ethnic mortality comparison showed that, compared with White patients, Black patients had greater odds of mortality (adjusted odds ratio [aOR], 1.53; 95% CI, 1.06-2.21; P = .02), and Hispanic patients had lower mortality (aOR, 0.73; 95% CI, 0.54-0.98; P = .04). A higher proportion of rebleeding, fewer early (within 24 hours) endoscopy, and delayed presentation marked by advanced disease on hospital admission represented some of the reasons for higher mortality in Black patients.
Table.

Characteristics of Patients Hospitalized With Variceal Upper Gastrointestinal Hemorrhage, 2008-2018

VariableHospitalizations by year, No. (%)P valuea
200820102012201420162018
No. of hospitalizations36 11637 39238 62538 78539 41944 645NA
Incidence per 100 000 persons11.8212.0912.3112.1812.2113.67<.001
Sex
Male24 743 (68.5)26 223 (70.1)26 908 (70.0)26 510 (68.4)26 629 (67.6)30 380 (68.0).18
Female11 373 (31.5)11 169 (29.9)11 717 (30.3)12 275 (31.6)12 790 (32.4)14 265 (32.0).18
Age, mean, y55.9955.4056.0356.4856.4456.59<.001
Length of hospital stay, mean, d6.456.456.336.296.156.17.01
Mortality rate in different racial groupsb
Asian58 (7.3)118 (16.0)70 (8.4)130 (12.6)140 (14.2)85 (7.3).71
Black395 (18.2)482 (16.9)435 (16.2)440 (15.0)525 (17.5)455 (15.0).03
Hispanic609 (10.7)567 (8.1)715 (9.4)645 (8.4)650 (8.4)660 (7.3).004
White2054 (10.6)2118 (9.8)2224 (9.5)2265 (9.8)2315 (9.7)2640 (9.5).06
Overall3935 (10.9)3703 (10.0)3895 (10.1)3970 (10.2)4020 (10.2)4280 (9.6).003

Linear trend P value.

Adjusted for age and sex.

Figure.

Trends in Racial and Ethnic Distribution of Patients Hospitalized With Variceal Upper Gastrointestinal Hemorrhage, 2008-2018

Linear trend P value. Adjusted for age and sex.

Discussion

Hispanic individuals were found to have the highest incidence of VUGIH, followed by White individuals, with an increasing trend in the studied cohort. Contrary to the incidence, Black individuals had the highest mortality rate compared with White individuals, and Hispanic individuals had lower mortality rates. These racial and ethnic differences could occur due to differences in the prevalence of risk factors, including smoking, alcohol consumption, hepatitis, steatohepatitis, platelet inhibition, anticoagulant use, comorbidities, and delayed and disproportionate access to health care, as previous literature suggested[2]; however, further research may help elucidate whether racial and ethnic or genetic factors are also at play. In this cohort, overall mortality showed a downward longitudinal trend in all groups, likely partly due to readily available direct-acting antivirals for hepatitis C infection and its eradication.[4] Despite this decreasing trend, Black individuals had 52% higher odds of mortality than White individuals. Nationwide strategies are needed to further reduce the mortality gap among different racial and ethnic groups. Nonalcoholic steatohepatitis is projected to be the leading cause of liver disease–related mortality and morbidity; several clinical trials testing various drugs are currently under development.[5] A limitation of this study is the inability to control for cirrhosis stage based on Child-Pugh or Model for End-stage Liver Disease score and reliance on ICD codes. However, we applied the Charlson Comorbidity Index for comorbidity burden and also controlled for major comorbidities included in the Rockall score.
  4 in total

1.  The in-hospital mortality rate for upper GI hemorrhage has decreased over 2 decades in the United States: a nationwide analysis.

Authors:  Marwan S Abougergi; Anne C Travis; John R Saltzman
Journal:  Gastrointest Endosc       Date:  2014-12-05       Impact factor: 9.427

2.  Impact of ethnicity in upper gastrointestinal hemorrhage.

Authors:  Casey S Wollenman; Rebecca Chason; Joan S Reisch; Don C Rockey
Journal:  J Clin Gastroenterol       Date:  2014-04       Impact factor: 3.062

Review 3.  Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail.

Authors:  Mithun Sharma; Madhumita Premkumar; Anand V Kulkarni; Pramod Kumar; D Nageshwar Reddy; Nagaraja Padaki Rao
Journal:  J Clin Transl Hepatol       Date:  2020-12-09

4.  A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments.

Authors:  Andrew Radley; Emma Robinson; Esther J Aspinall; Kathryn Angus; Lex Tan; John F Dillon
Journal:  BMC Health Serv Res       Date:  2019-10-28       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.